Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16343291rdf:typepubmed:Citationlld:pubmed
pubmed-article:16343291lifeskim:mentionsumls-concept:C2698565lld:lifeskim
pubmed-article:16343291lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:16343291lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:16343291lifeskim:mentionsumls-concept:C0005508lld:lifeskim
pubmed-article:16343291lifeskim:mentionsumls-concept:C0552567lld:lifeskim
pubmed-article:16343291pubmed:issue6lld:pubmed
pubmed-article:16343291pubmed:dateCreated2005-12-13lld:pubmed
pubmed-article:16343291pubmed:abstractTextThe pharmacokinetic properties of pentoxyfylline and its metabolites were determined in healthy chickens after single intravenous and oral dosage of 100 mg/kg pentoxyfylline. Plasma concentrations of pentoxyfylline and its metabolites were determined by a validated high-performance liquid chromatographic method. After intravenous (i.v.) and oral (p.o.) administration, the plasma concentration-time curves were best described by a one-compartment open model. The mean elimination half-life (t(1/2el)) of pentoxyfylline was 1.05 h, total body clearance 1.90 L/h x kg, volume of distribution 2.40 L/kg and the mean residence time was 2.73 h, after i.v. administration. After oral dosing, mean maximal plasma concentration of pentoxyfylline was 4.01 microg/mL and the interval from p.o. administration until maximum concentration was 1.15 h. The mean oral bioavailability was found to be 28.2%. Metabolites I, IV and V were present in chicken plasma after both i.v. and p.o. administration, with metabolite V being the most dominant.lld:pubmed
pubmed-article:16343291pubmed:languageenglld:pubmed
pubmed-article:16343291pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16343291pubmed:citationSubsetIMlld:pubmed
pubmed-article:16343291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16343291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16343291pubmed:statusMEDLINElld:pubmed
pubmed-article:16343291pubmed:monthDeclld:pubmed
pubmed-article:16343291pubmed:issn0140-7783lld:pubmed
pubmed-article:16343291pubmed:authorpubmed-author:De BackerPPlld:pubmed
pubmed-article:16343291pubmed:authorpubmed-author:CroubelsSSlld:pubmed
pubmed-article:16343291pubmed:authorpubmed-author:BaertKKlld:pubmed
pubmed-article:16343291pubmed:authorpubmed-author:De BoeverSSlld:pubmed
pubmed-article:16343291pubmed:issnTypePrintlld:pubmed
pubmed-article:16343291pubmed:volume28lld:pubmed
pubmed-article:16343291pubmed:ownerNLMlld:pubmed
pubmed-article:16343291pubmed:authorsCompleteYlld:pubmed
pubmed-article:16343291pubmed:pagination575-80lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:meshHeadingpubmed-meshheading:16343291...lld:pubmed
pubmed-article:16343291pubmed:year2005lld:pubmed
pubmed-article:16343291pubmed:articleTitlePharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.lld:pubmed
pubmed-article:16343291pubmed:affiliationDepartment of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. sandra.deboever@ugent.belld:pubmed
pubmed-article:16343291pubmed:publicationTypeJournal Articlelld:pubmed